Work

Ultrasound-Guided Baxter Nerve, Flexor Digitorum Brevis, or Combined Injections for Plantar Heel Pain Associated With Calcaneal Spur: A Prospective Randomized Controlled Trial

Year: 2026
Type: preprint
Abstract: Background Plantar heel pain associated with calcaneal spur is common. This randomized controlled trial compared ultrasound-guided Baxter nerve, flexor digitorum brevis (FDB) origin, and combined injections. Methods A total of 210 patients with plantar heel pain associated with calcaneal spur were randomized 1:1:1 using a computer-generated block randomization sequence. Participants received ultrasound-guided injection targeting the Baxter nerve, FDB origin, or both sites. The primary outcome was longitudinal change in pain intensity measured using a 0- to 10-cm Visual Analog Scale (VAS) at 1, 3, and 6 months. The secondary outcome was longitudinal change in the Foot Function Index (FFI). Outcomes were analyzed using linear mixed-effects models with treatment, time, treatment-by-time interaction, and baseline outcome values as fixed effects and participant as a random intercept. Results Of 210 participants, 202 completed follow-up and were included in the analysis. Treatment-by-time interaction was significant for VAS (χ² = 155.21, df = 4, P < .001) and FFI (χ² = 148.65, df = 4, P < .001). At 6 months, the adjusted VAS difference was − 4.77 points (95% CI, − 5.67 to − 3.88; Holm-adjusted P < .001) for Baxter nerve versus FDB injection and − 4.52 points (95% CI, − 5.41 to − 3.63; Holm-adjusted P < .001) versus combined injection. FFI differences were − 0.343 (95% CI, − 0.412 to − 0.273; Holm-adjusted P < .001) and − 0.360 (95% CI, − 0.430 to − 0.290; Holm-adjusted P < .001), respectively. No treatment-related adverse events were observed. Conclusions In patients with plantar heel pain associated with calcaneal spur, ultrasound-guided Baxter nerve injection resulted in greater improvements in pain and foot function through 6 months than FDB origin or combined injection. These findings support Baxter nerve-targeted injection as an effective treatment option. Trial registration ClinicalTrials.gov, NCT07884695. First posted 20 October 2026. Retrospectively registered.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7234721288
Cites: 29
Cited by:
Related to: 10